ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2023

Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France.

Manon Belhassen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.